Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

HIPPOCRATES: improving diagnosis and outcomes in psoriatic arthritis

Nature Reviews Rheumatology volume 18, pages 123–124 (2022)Cite this article

Subjects

Combining the diverse expertise of clinical and scientific researchers from across Europe as well as patient representatives and pharmaceutical industry partners, the HIPPOCRATES consortium aims to characterize the molecular pathways underlying psoriatic arthritis in order to improve early diagnosis and precision treatment strategies for the disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Progress in psoriatic disease biomarker development after HIPPOCRATES.

References

  1. Jadon, D. R., Stober, C., Pennington, S. R. & FitzGerald, O. Applying precision medicine to unmet clinical needs in psoriatic disease. Nat. Rev. Rheumatol. 16, 609–627 (2020).

    Article  Google Scholar 

  2. Ritchlin, C. T., Colbert, R. A. & Gladman, D. D. Psoriatic arthritis. N. Engl. J. Med. 376, 2095–2096 (2017).

    Article  Google Scholar 

  3. Szentpetery, A. et al. Higher coronary plaque burden in psoriatic arthritis is independent of metabolic syndrome and associated with underlying disease severity. Arthritis Rheumatol. 70, 396–407 (2018).

    Article  Google Scholar 

  4. Haroon, M., Gallagher, P. & FitzGerald, O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann. Rheum. Dis. 74, 1045–50 (2015).

    Article  CAS  Google Scholar 

  5. Pouw, J., Leijten, E., Radstake, T. & Boes, M. Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: a review of literature. Clin. Immunol. 211, 108318 (2020).

    Article  CAS  Google Scholar 

  6. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. GRAPPA EU. https://www.grappanetwork.org/grappa-eu (2022).

  7. Poste, G. Bring on the biomarkers. Nature 469, 156–157 (2011).

    Article  CAS  Google Scholar 

  8. National Institutes of Health. Accelerating Medicines Partnership® Program: Autoimmune and Immune-Mediated Diseases (AMP® AIM). https://www.niams.nih.gov/grants-funding/niams-supported-research-programs/accelerating-medicines-partnership-amp (2021).

Download references

Acknowledgements

The authors wish to acknowledge all members of the HIPPOCRATES consortium, and in particular thank Maarten de Wit, representing patient research partners, and Christine Huppertz, representing European Federation of Pharmaceutical Industries and Associations (EFPIA) partners, for contributions to this manuscript. HIPPOCRATES has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 101007757. The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Author information

Authors and Affiliations

  1. Conway Institute for Biomolecular Research, School of Medicine, University College Dublin, Dublin, Ireland

    Oliver FitzGerald & Stephen R. Pennington

Authors
  1. Oliver FitzGerald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen R. Pennington
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oliver FitzGerald.

Ethics declarations

Competing interests

O.F. has received research support and/or honoraria from Novartis, BMS, Pfizer, AbbVie, UCB, Lilly, Janssen and Biogen. S.R.P. has received research support from Lilly and Pfizer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

FitzGerald, O., Pennington, S.R. HIPPOCRATES: improving diagnosis and outcomes in psoriatic arthritis. Nat Rev Rheumatol 18, 123–124 (2022). https://doi.org/10.1038/s41584-022-00748-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-022-00748-w

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing